Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Milad Pourbaghi-Masouleh"'
Autor:
Anne Clavreul, Emilie Roger, Milad Pourbaghi-Masouleh, Laurent Lemaire, Clément Tétaud, Philippe Menei
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1756-1765 (2018)
Anticancer agents that target both tumor cells and angiogenesis are of potential interest for glioblastoma (GB) therapy. One such agent is sorafenib (SFN), a tyrosine kinase inhibitor. However, poor aqueous solubility and undesirable side effects lim
Externí odkaz:
https://doaj.org/article/9a7418f8f4d44aa482de42d70a3aa2b0
Autor:
Anne Clavreul, Milad Pourbaghi-Masouleh, Emilie Roger, Nolwenn Lautram, Claudia N. Montero-Menei, Philippe Menei
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background Glioblastoma (GB) is the most malignant brain tumor in adults. It is characterized by angiogenesis and a high proliferative and invasive capacity. Standard therapy (surgery, radiotherapy and chemotherapy with temozolomide) is of l
Externí odkaz:
https://doaj.org/article/08d25ce25fa54c9992d270825ec759e2
Publikováno v:
Bioinorganic Chemistry and Applications, Vol 2012 (2012)
This paper describes some physical, structural, and biological properties of gypsum bioceramics doped with various amounts of strontium ions (0.19–2.23 wt%) and compares these properties with those of a pure gypsum as control. Strontium-doped gypsu
Externí odkaz:
https://doaj.org/article/a2fefb14fe03494dabbbff0ee9a23f97
Publikováno v:
International Journal of Nanomedicine. 14:2497-2513
Angiogenesis, the formation of new blood vessels, is an essential component of glioblastoma (GB) progression. The development of angiogenesis inhibitor therapy, including treatments targeting vascular endothelial growth factor (VEGF) in particular, r
Autor:
Rachael W. Sirianni, Martha J Fowler, Oluwatobi Babayemi, Sara Belko, Cassandra Baker, Sarah E. Stabenfeldt, Milad Pourbaghi Masouleh, Kyle T. Householder
Nanoparticle systems are often used to facilitate drug delivery to the central nervous system (CNS). There are many clinical situations in which CNS tissue might be removed prior to administration of a therapeutic nanoparticle; however, the iatrogeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed4d3ab0cf2af729029a768e2d65950d
https://doi.org/10.21203/rs.3.rs-704464/v1
https://doi.org/10.21203/rs.3.rs-704464/v1
Autor:
Clément Tétaud, Emilie Roger, Laurent Lemaire, Philippe Menei, Anne Clavreul, Milad Pourbaghi-Masouleh
Publikováno v:
Drug Delivery
Drug Delivery, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Taylor & Francis, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Vol 25, Iss 1, Pp 1756-1765 (2018)
Drug Delivery, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Taylor & Francis, 2018, 25 (1), pp.1756-1765. ⟨10.1080/10717544.2018.1507061⟩
Drug Delivery, Vol 25, Iss 1, Pp 1756-1765 (2018)
International audience; Anticancer agents that target both tumor cells and angiogenesis are of potential interest for glioblastoma (GB) therapy. One such agent is sorafenib (SFN), a tyrosine kinase inhibitor. However, poor aqueous solubility and unde
Publikováno v:
International Journal of Nanomedicine
Angiogenesis, the formation of new blood vessels, is an essential component of glioblastoma (GB) progression. The development of angiogenesis inhibitor therapy, including treatments targeting vascular endothelial growth factor (VEGF) in particular, r
Autor:
Milad Pourbaghi-Masouleh, Philippe Menei, Anne Clavreul, Nolwenn Lautram, Emilie Roger, Claudia N. Montero-Menei
Publikováno v:
Journal of Experimental and Clinical Cancer Research
Journal of Experimental and Clinical Cancer Research, BioMed Central, 2017, 36 (1), pp.135. ⟨10.1186/s13046-017-0605-2⟩
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-11 (2017)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental and Clinical Cancer Research, 2017, 36 (1), pp.135. ⟨10.1186/s13046-017-0605-2⟩
Journal of Experimental and Clinical Cancer Research, BioMed Central, 2017, 36 (1), pp.135. ⟨10.1186/s13046-017-0605-2⟩
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-11 (2017)
Journal of Experimental & Clinical Cancer Research : CR
Journal of Experimental and Clinical Cancer Research, 2017, 36 (1), pp.135. ⟨10.1186/s13046-017-0605-2⟩
International audience; Background: Glioblastoma (GB) is the most malignant brain tumor in adults. It is characterized by angiogenesis and a high proliferative and invasive capacity. Standard therapy (surgery, radiotherapy and chemotherapy with temoz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8a177fd9b0b72de96f145828dbcb93d
https://www.hal.inserm.fr/inserm-01631360/document
https://www.hal.inserm.fr/inserm-01631360/document
Publikováno v:
Materials Letters. 113:130-133
Gentamicin sulfate (GS) is an antibiotic, used to treat many types of bacterial infections, particularly those caused by gram-negative organisms, not only through colloidal delivery system, but also in tissue engineering scaffolds. On the other hand,
Publikováno v:
Materials Science-Poland. 31:424-433
In this study, the Taguchi method of design of experiment (DOE) was used to optimize the hydroxyapatite (HA) coatings on various metallic substrates deposited by sol-gel dip-coating technique. The experimental design consisted of five factors includi